| 翻訳と辞書 |
| Conjoint analysis (healthcare) ： ウィキペディア英語版 |
Conjoint analysis (healthcare)
''See also: Conjoint analysis (in marketing), Rule Developing Experimentation''
==Why conjoint in healthcare market research?==
Pharmaceutical manufacturers need deeper and deeper market information they can rely on to make the right decisions and to identify the most promising market opportunities()() . They can obtain great benefits from understanding physicians’ prescription preferences and opinions, as these are the key people in prescribing medical treatments. Consequently, conjoint analysis research projects might represent a remarkable help for pharmaceutical companies during the development of new drugs, and if properly conducted they might even allow the estimation of product sale and market share().
Conjoint analysis() () is a multivariate statistical technique based on the study of the joint effects on consumers of the elements that compose a product or service; it allows eliciting the relative importance of such elements. Therefore, by an additive model, it allows the estimation of the total utility of different profiles or combinations of attributes, and consequently, it allows the identification of the optimal configuration for a new or existing product or service. This technique was first developed in the early 1970s by Green and Rao() . Since then, it has received increasing academic and private sector attention.
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「Conjoint analysis (healthcare)」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|